Chemotherapy after scope for upper urinary tract cancer
Part of Cancer, Kidney & urinary clinical trials.
This study is testing whether giving a single dose of chemotherapy directly into the kidney and ureter right after a scope procedure helps prevent upper urinary tract tumors from coming back. It’s for people who are about to have a scope to diagnose or treat a suspected or known tumor in the upper urinary tract.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or known cancer in the upper part of your urinary tract (kidney or ureter).
- You are planning to have a scope procedure (ureteroscopy) to look at or treat the tumor.
- You are 18 years or older.
- You are able to carry out daily activities with little help (ECOG score 0-2).
- If you have had bladder cancer, it must be at least 2 years since your last treatment, and you must not be getting bladder wash (irrigation) treatment.
- If you have had a previous upper-tract tumor, it must be more than 1 year since your last treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy before surgery can improve outcomes for people with high-risk cancer in the upper urinary tract (the tubes that carry urine from the kidneys to the bladder). The chemotherapy is given before the standard surgery to remove the affected kidney and ureter.
This trial tests a combination of chemotherapy (gemcitabine) and a targeted drug (Trastuzumab Rezetecan) before surgery to remove the kidney and ureter. It may help shrink the tumor and improve outcomes for people with HER2-positive upper tract urothelial cancer.
This trial tests whether giving a chemotherapy drug called mitomycin C directly into the bladder after a ureteroscopy can help prevent upper tract urothelial cancer from coming back or spreading. It is for people who are newly suspected of having this cancer and are about to have a diagnostic ureteroscopy.
This study tests whether giving a single dose of chemotherapy directly into the bladder right after a diagnostic scope procedure can help prevent the cancer from coming back in people with a new diagnosis of cancer in the kidney or ureter. It is an extra step that may reduce the risk of recurrence without delaying standard care.
This Phase 3 trial studies whether using gemcitabine (a chemotherapy medicine) in the urinary tract better prevents cancer from coming back than using a simple water wash. It involves people with upper tract urothelial carcinoma who are having curative surgery to remove the affected ureter or kidney tube.
This trial is testing whether adding immunotherapy and radiation after surgery can improve outcomes for people with advanced upper tract urothelial cancer (UTUC) who cannot have chemotherapy. It compares the combination to surgery alone.
Hear when a new UTUC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.